Jefferies Remains Bullish on NVIDIA Corporation (NVDA)

Core Viewpoint - NVIDIA Corporation (NASDAQ:NVDA) is considered one of the best stocks to buy in 2026 for beginners, with analysts highlighting its potential for growth and current valuation as attractive [1]. Group 1: Analyst Ratings and Price Targets - Jefferies raised the price target for NVIDIA to $275 from $250, maintaining a Buy rating and indicating that the stock is "pretty cheap" based on its valuation metrics [1]. - J.P. Morgan reiterated a Buy rating on NVIDIA without a specific price target, emphasizing the company's pivotal role in modern drug discovery through its GPU infrastructure [2]. - Wells Fargo also reiterated a Buy rating on NVIDIA, setting a price target of $265 [4]. Group 2: Strategic Partnerships and Market Position - NVIDIA's $1 billion co-innovation partnership with Eli Lilly is highlighted as a significant factor supporting durable demand for its products in the pharmaceutical sector [2]. - The company's expanding role in life sciences and healthcare is noted, with its full-stack approach providing significant operating leverage across various applications [3]. Group 3: Technological Advancements and Cost Efficiency - NVIDIA's advancements in robotics, integrated simulation, and edge-compute technology are enabling automation in healthcare laboratories, which could drastically reduce costs and increase throughput [4].